$85.11
Value $410M
CHMG and MS stock compared: price, dividend, valuation and results, from SEC filings.
$85.11
Value $410M
$190.65
Value $303B
Chemung Financial (CHMG) has a market value of $410M and Morgan Stanley (MS) $303B. Over the last year, with dividends, CHMG moved +66.2% and MS +14.7%. The P/E is 10.7 for CHMG and 15.3 for MS. Dividend yield: CHMG 1.62%, MS 2.26%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
CHMG$410M
MS$303B
MS is 738 times CHMG
Revenue, 12 months
CHMG$124M
MS$80.2B
MS is 649 times CHMG
Net income, 12 months
CHMG$38M
MS$20.5B
MS is 532 times CHMG
Operating margin
CHMG–
MS–
ROIC
CHMG14.7%
MS4.4%
10.3 points apart
P/E
CHMG10.7
MS15.3
MS is 1.4 times CHMG
Dividend yield
CHMG1.6%
MS2.3%
0.7 points apart
5-year return
CHMG+101.7%
MS+123.5%
21.8 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
CHMG+101.8%
MS+123.5%
| Period | CHMGWith dividends | MSWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +66.2%Price +62.7% | +14.7%Price +12.2% |
| 3 years since November 13, 2023 | +112.9%+28.6% a yearPrice +97.5% | +176.8%+40.4% a yearPrice +154.1% |
| 5 years since November 12, 2021 | +101.7%+15.1% a yearPrice +76.6% | +123.5%+17.5% a yearPrice +90.9% |
| 10 years since November 15, 2016 | +252.7%+13.4% a yearPrice +170.2% | +530.5%+20.2% a yearPrice +376.6% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
CHMGChemung FinancialMSMorgan Stanley
| Price | $85.11 | $190.65 |
|---|---|---|
| Market value | $410M | $303B |
| Enterprise value (EV) | – | – |
| P/E | 10.7 | 15.3 |
| P/E, 5-year median | 9.4 | 15.8 |
| P/B | 1.5 | 2.6 |
| EV/EBIT | – | – |
| Free cash flow yield | – | – |
| Revenue, 12 months | $124M | $80.2B |
|---|---|---|
| Net income, 12 months | $38M | $20.5B |
| Free cash flow, 12 months | – | – |
| Earnings per share, 12 months | $7.97 | $12.60 |
| Revenue growth, year on year | -2.3% | 14.4% |
| Revenue growth a year, past | +2.5%over 5 years | +7.7%over 5 years |
| EPS growth a year, past | -4.8%over 5 years | +9.6%over 5 years |
| Gross margin | – | – |
|---|---|---|
| Operating margin | – | – |
| Net margin | 31.1% | 25.5% |
| ROIC | 14.7% | 4.4% |
| ROE | 14.7% | 18.0% |
| Cash | $89M | $244B |
|---|---|---|
| Total debt | $44M | $378B |
| Net debt / EBITDA | – | – |
| Interest cover | – | – |
| Dividend yield | 1.6% | 2.3% |
|---|---|---|
| Dividend per share, 12 months | $1.38 | $4.30 |
| Dividend growth a year, past | +4.9%over 5 years | – |
| Buyback yield | 0.1% | 1.5% |
| Shareholder yield | 1.7% | 3.8% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Morgan Stanley ($303B) is about 738.2 times Chemung Financial ($410M), at today's prices.
Since November 15, 2016, CHMG's price moved +170.2% and MS's +376.6%. With dividends: CHMG +252.7% (+13.4% a year), MS +530.5% (+20.2% a year). Past returns do not predict future ones.
The dividend yield at today's price is 1.62% for Chemung Financial and 2.26% for Morgan Stanley. Over the last twelve months they paid $1.38 and $4.30 per share.
At today's price, the P/E is 10.7 for CHMG and 15.3 for MS. The median of the last five years was 9.4 and 15.8, which shows where each stands against its own past.
Over the last twelve months, the net margin was 31.1% for Chemung Financial and 25.5% for Morgan Stanley, and the operating margin – and –. Revenue was $124M and $80.2B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.